Associated Papers
Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances.
Hasanau T et al.
Biomedicines, 2022
Detection of TERT Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error.
Lee H et al.
Cancer Research and Treatment, 2022
Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.
Soares P et al.
Endocrine Pathology, 2021
EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion.
Castagna MG et al.
Archives of Endocrinology and Metabolism, 2020
Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme.
Jeong DE et al.
Oncology Letters, 2017
Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma.
Panero J et al.
American Journal of Hematology, 2016
Liquid biopsy with multiplex ligation-dependent probe amplification targeting cell-free tumor DNA in cerebrospinal fluid from patients with adult diffuse glioma.
Otsuji R et al.
Neuro-oncology Advances, 0
Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting CDKN2A/B status.
Tosefsky K et al.
Neuro-oncology Advances, 0
Select a paper to view details